Inflammatory Response in Aortic Valve Replacement

NCT02324140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2015-07-14

No results posted yet for this study

Summary

The study investigates inflammatory and antiinflammatory response in patients with severe aortic valve stenosis needing either surgical treatment (surgical aortic valve replacement) or interventional cardiology treatment (transcatheter aortic valve implantation using the transfemoral access route or the transapical access route).

Conditions

  • Inflammation
  • Systemic Inflammatory Response Syndrome
  • Thoracic Surgery
  • Aortic Valve Stenosis

Interventions

OTHER

Whole blood analysis

In all fours groups of patients we investigate inflammatory and antiinflammatory response to the surgical and interventional treatment by analyzing changes in the concentration of interleukins, C-reactive protein, soluble CD62L and HLA-DR.

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Frank Stüber, MD, Prof. · Dep. Anesthesiology and pain Therapy

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-03-31
Completion
2015-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324140 on ClinicalTrials.gov